Risks for Developing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in College Students Following Infectious Mononucleosis: A Prospective Cohort Study. — CFSMEATLAS
Risks for Developing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in College Students Following Infectious Mononucleosis: A Prospective Cohort Study.
Jason, Leonard A, Cotler, Joseph, Islam, Mohammed F et al. · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021 · DOI
Quick Summary
This study followed college students to see who developed ME/CFS after getting infectious mononucleosis (mono). Researchers found that about 23% of students who got mono later met criteria for ME/CFS within 6 months. Before getting mono, students who later developed ME/CFS had more physical symptoms and certain immune markers that were different from those who recovered, but they didn't have more stress, anxiety, or depression.
Why It Matters
This study is important because it provides prospective evidence that certain physical and immune characteristics before infection may predict who develops ME/CFS after mono—not psychological factors alone. This challenges assumptions that ME/CFS is primarily psychologically-driven and suggests biological vulnerability markers that could guide early identification and intervention.
Observed Findings
23% of college students who developed infectious mononucleosis met ME/CFS criteria 6 months later, while 66% fully recovered
At baseline (before mono), future ME/CFS patients had lower IL-6 and IL-13 immune markers compared to those who recovered, despite having similar stress and psychological symptoms
At mono onset, students who developed ME/CFS showed more autonomic complaints and higher IL-12 with lower IL-13 compared to the recovered group
Physical symptoms (but not psychological symptoms like anxiety or depression) at baseline predicted who would develop ME/CFS after mono
Inferred Conclusions
Certain immune dysregulation patterns present before infection may identify students at biological risk for developing ME/CFS following mono
ME/CFS development after infection is not predicted by baseline psychological stress or emotional health, suggesting a primarily biological rather than psychologically-driven susceptibility
Immune dysregulation at the time of acute infection (higher IL-12, lower IL-13) is associated with progression to ME/CFS rather than full recovery
Remaining Questions
What specific mechanisms explain why low baseline IL-6 and IL-13 increase risk for ME/CFS, and can these be therapeutically targeted?
Do the immune markers and physical symptoms identified in this college population predict ME/CFS risk after other infections or in different age groups?
What This Study Does Not Prove
This study does not prove that the immune markers identified cause ME/CFS, only that they are associated with it. The findings are limited to college students with mono and may not apply to ME/CFS developing from other infections or in other populations. Additionally, the study cannot explain the biological mechanisms behind why these immune patterns predict ME/CFS development.
What determines whether someone with these biological risk factors progresses to severe ME/CFS versus mild ME/CFS, and can interventions at mono onset prevent ME/CFS development?
Are there genetic factors underlying the immune dysregulation patterns that predict ME/CFS susceptibility?